These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1125562)

  • 1. Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.
    Staughton RC; August PJ
    Br Med J; 1975 May; 2(5968):419-21. PubMed ID: 1125562
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
    Walsh P; Aeling JL; Huff L; Weston WL
    J Am Acad Dermatol; 1993 Sep; 29(3):501-3. PubMed ID: 8349876
    [No Abstract]   [Full Text] [Related]  

  • 3. Adrenal suppression following low-dose topical clobetasol propionate.
    Ohman EM; Rogers S; Meenan FO; McKenna TJ
    J R Soc Med; 1987 Jul; 80(7):422-4. PubMed ID: 3656312
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.
    Munro DD; Wilson L
    Br Med J; 1975 Sep; 3(5984):626-8. PubMed ID: 1164639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Short-term safety assessment of clobetasol propionate 0.05% shampoo: hypothalamic-pituitary-adrenal axis suppression, atrophogenicity, and ocular safety in subjects with scalp psoriasis.
    Andres P; Poncet M; Farzaneh S; Soto P
    J Drugs Dermatol; 2006 Apr; 5(4):328-32. PubMed ID: 16673799
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.
    Kimball AB; Gold MH; Zib B; Davis MW;
    J Am Acad Dermatol; 2008 Sep; 59(3):448-54, 454.e1. PubMed ID: 18539358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate.
    Young CA; Williams IR; MacFarlane IA
    Br J Clin Pract; 1991; 45(1):61-2. PubMed ID: 1931550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.
    Silver S; Tuppal R; Gupta AK; Clonier F; Olesen M; Leeder R; Taraska V
    J Drugs Dermatol; 2013 Aug; 12(8):882-7. PubMed ID: 23986161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].
    van der Harst LC; Smeenk G; Burger PM; van der Rhee HJ; Polano MK
    Ned Tijdschr Geneeskd; 1978 Feb; 122(7):219-23. PubMed ID: 345134
    [No Abstract]   [Full Text] [Related]  

  • 10. Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.
    Fleming C; Ganslandt C; Leese GP
    J Drugs Dermatol; 2010 Aug; 9(8):969-74. PubMed ID: 20684147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beclomethasone dipropionate enemas for treating inflammatory bowel disease without producing Cushing's syndrome or hypothalamic pituitary adrenal suppression.
    Kumana CR; Seaton T; Meghji M; Castelli M; Benson R; Sivakumaran T
    Lancet; 1982 Mar; 1(8272):579-83. PubMed ID: 6121181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cushing's syndrome with suppression of the hypothalamic-pituitary-adrenal axis after intra-articular steroid injections.
    O'Sullivan MM; Rumfeld WR; Jones MK; Williams BD
    Ann Rheum Dis; 1985 Aug; 44(8):561-3. PubMed ID: 4026419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Guidelines for using superpotent topical steroids.
    Prawer SE; Katz HI
    Am Fam Physician; 1990 May; 41(5):1531-8. PubMed ID: 2333829
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypothalamic-pituitary-adrenal axis function in premature neonates after extensive prenatal treatment with betamethasone: a case history.
    Kairalla AB
    Am J Perinatol; 1992; 9(5-6):428-30. PubMed ID: 1418149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy, safety, and cost-effectiveness of all-trans retinoic acid/Clobetasol Propionate Compound Ointment in the treatment of mild to moderate psoriasis vulgaris: A randomized, single-blind, multicenter clinical trial.
    Xia L; Li R; Wang Y; Lin Z; Zheng J; Li X; Lu Q; Zhang J; Jin H; Fu L; Zhang X; Liu Y; Yang S; Xiao F; Gao XH
    Dermatol Ther; 2018 Sep; 31(5):e12632. PubMed ID: 30253049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypothalamic-pituitary-adrenocortical function. Association with topical application of betamethasone dipropionate.
    Reymann F; Kehlet H
    Arch Dermatol; 1979 Mar; 115(3):362-3. PubMed ID: 219785
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of clobetasol propionate and betamethasone-17,21-dipropionate with reference to adrenal suppression.
    Eriksen K
    Acta Derm Venereol; 1979; 59(4):372-4. PubMed ID: 92159
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cushing's syndrome, topical steroids, and cling film.
    Fairris GM; White JE; Tymms DJ; Leatherdale BA
    Lancet; 1986 Jul; 2(8500):228. PubMed ID: 2873479
    [No Abstract]   [Full Text] [Related]  

  • 19. [Adrenal insufficiency and iatrogenic Cushing's syndrome by cutaneous absorption of corticosteroids in an 8 month old infant].
    Dandine M; Lavaud J; Besson-Léaud M; Limal JM
    Ann Dermatol Venereol; 1980 Mar; 107(3):191-5. PubMed ID: 7258980
    [No Abstract]   [Full Text] [Related]  

  • 20. The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease.
    Avgerinos PC; Nieman LK; Oldfield EH; Loughlin T; Barnes KM; Loriaux DL; Cutler GB
    J Clin Endocrinol Metab; 1989 May; 68(5):912-6. PubMed ID: 2541160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.